Rockley Photonics Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Rockley Photonics Holdings wird ein Gewinn- und Umsatzwachstum von 12.9% bzw. 196.2% pro Jahr prognostiziert, während der Gewinn pro Aktie um 27.4% pro Jahr wachsen soll.

Wichtige Informationen

12.9%

Wachstumsrate der Gewinne

27.4%

EPS-Wachstumsrate

Semiconductor Gewinnwachstum	26.5%
Wachstumsrate der Einnahmen	196.2%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	26 Jan 2023

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Rockley Photonics promotes Richard Meier to CEO, replacing Andrew Rickman

Dec 12

Rockley Non-GAAP EPS of $0.14 beats by $0.40, revenue of $0.56M misses by $0.94M

Nov 09

Gewinn- und Umsatzwachstumsprognosen

OTCPK:RKLY.Q - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2023	50	-161	-65	-64	1
12/31/2022	4	N/A	-149	-145	1
9/30/2022	5	-166	-157	-151	N/A
6/30/2022	7	-236	-159	-152	N/A
3/31/2022	7	-145	-149	-140	N/A
12/31/2021	8	-168	-134	-126	N/A
9/30/2021	9	-187	-118	-112	N/A
6/30/2021	12	-149	-94	-90	N/A
3/31/2021	17	-129	-61	-59	N/A
12/31/2020	22	-80	-50	-48	N/A
12/31/2019	20	-51	-40	-37	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: RKLY.Q wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: RKLY.Q wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: RKLY.Q wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: RKLY.QDie Einnahmen des Unternehmens (196.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.4% pro Jahr).

Hohe Wachstumseinnahmen: RKLY.QDie Einnahmen des Unternehmens (196.2% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von RKLY.Q in 3 Jahren voraussichtlich hoch sein wird

Rockley Photonics Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus forecasts updated

Price target increased to US$8.00

Consensus EPS estimates fall by 16%

Rockley Photonics Holdings Limited Provides Revenue Guidance for the Fiscal Year 2022

No longer forecast to breakeven

No longer forecast to breakeven

Recent updates

Bragar Eagel & Squire, P.C. Files Class Action Lawsuit Against Rockley Photonics Holdings Limited

Rockley Photonics Begins Sampling Bioptx™ Biosensing Band and Platform

Robbins Geller Rudman & Dowd LLP Announces the Rockley Class Action Lawsuit Charges Sc Health Holdings Limited, Sc Health Group Limited, Sin Capital Group Pte. Ltd. and Certain of Sc Health, Sin Capital Group Pte. Ltd

Rockley Photonics Advances Non-Invasive Blood Glucose Monitoring

Rockley Photonics Advances Development of Its Wearable, Laser-Based Blood Pressure Monitor with Successful Completion of Human Studies

Rockley Photonics Holdings Limited Launches Developer Platform for Biomarker Data Collection in Free-Living Conditions

Rockley Photonics Holdings Limited(NYSE:RKLY) dropped from S&P TMI Index

Rockley Photonics Holdings Limited Filed for Bankruptcy

Rockley Photonics Announces Receipt of Notice from NYSE of Non-Compliance with Continued Listing Standards

Rockley Photonics Holdings Limited Announces Appointment of Richard Edward Kuntz as Director, with Effect from August 8, 2022

Rockley Photonics Holdings Limited Announces Management Changes

Rockley Photonics promotes Richard Meier to CEO, replacing Andrew Rickman

Rockley Photonics Demonstrates Compact 4-Kelvin Silicon Photonics Modulator Enabling Interconnect Technologies for Ultra-Sensitive Image Detection and Sensing Devices

Consensus forecasts updated

High number of new and inexperienced directors

Price target increased to US$8.00

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Rockley Non-GAAP EPS of $0.14 beats by $0.40, revenue of $0.56M misses by $0.94M

Rockley Photonics Holdings Limited to Report Q3, 2022 Results on Nov 09, 2022

Rockley Photonics Holdings Limited Appoints Richard A. "Randy" Meier as Chief Financial Officer

Rockley Photonics Holdings Limited Completes Human Study Demonstrating Promising Intra-Subject Tracking Against Standard Blood Pressure Cuff, Utilizing Its Non-Invasive, Cuffless, and Laser-Based Device

Rockley Photonics hires Richard Meier as CFO

Rockley Photonics Holdings Limited announced that it has received $12.4 million in funding

Rockley Photonics raises additional financing

Rockley Photonics Holdings Limited Unveils Next-Generation, Higher-Density Laser Spectrophotometer Chip for Wearable Health Monitoring

Consensus EPS estimates fall by 16%

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Rockley Photonics Holdings Limited Establishes Scientific Advisory Board of Prominent Scientists and Medical Experts

Rockley Photonics Names Richard Kuntz, M.D., M.Sc., to Its Board of Directors, Effective August 8, 2022

Rockley Photonics signs supply agreement for non-invasive biosensing wristband

Rockley Photonics enter partnership with leading contract research organization

Rockley Photonics Holdings Limited to Report Q2, 2022 Results on Aug 11, 2022

Rockley Photonics Holdings Limited Announces Biosensing Technology Enters Evaluation Phase by Leading Consumer Wearables Customer

Rockley Photonics Announces Senior Leadership Changes

Rockley Photonics Holdings Limited Provides Revenue Guidance for the Fiscal Year 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Rockley Photonics Holdings Limited Announces Shipment of Vitalspex Pro Biosensing Technology for Alcohol, Lactate, and Glucose Measurement

No longer forecast to breakeven

High number of new directors

Rockley Photonics Holdings Limited Announces Termination of Chief Operating Officer, Amit Nagra

Rockley Photonics Holdings Limited to Report Q1, 2022 Results on Apr 27, 2022

Chief Operating Officer exercised options to buy US$614k worth of stock.

Independent Director recently bought US$197k worth of stock

No longer forecast to breakeven

Rockley Photonics Holdings Limited Revises Revenue Guidance for the Fiscal Year 2022

Forecast to breakeven in 2024

Rockley Photonics Appoints Nicolaus Henke as Independent Director and Member of Nominating & Corporate Governance Committee

Rockley Photonics Promotes Industry Leaders to Key Senior Roles

Rockley Photonics Announces Bioptx™ Biomarker Sensing Platform for Professional Healthcare, Including First-of-its-Kind Non-Invasive, Continuous Biosensing Wristband

Chief Operating Officer exercised options to buy US$1.6m worth of stock.

Rockley Photonics Holdings Limited, Annual General Meeting, May 16, 2022

Rockley Photonics Reaches Key Milestone in the Development of Cuffless, Non-Invasive Blood Pressure Measurement on the Wrist, Potentially Enabling A New Measurement Technique for Cardiovascular Health

Forecast to breakeven in 2024

High number of new and inexperienced directors

Rockley Photonics Holdings Limited Announces Results of Preliminary Human Studies Involving Measurement of Core Body Temperature

Lead Independent Director recently bought US$165k worth of stock

Third quarter 2021 earnings released: US$0.54 loss per share

Rockley Photonics: Long Term Potential Of Wearables Chip Maker Is Truly Vast

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken